These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38030336)

  • 41. Subcutaneous Implantable Cardioverter Defibrillators: An Overview of Implantation Techniques and Clinical Outcomes.
    Al-Ghamdi B
    Curr Cardiol Rev; 2019; 15(1):38-48. PubMed ID: 30014805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.
    Fong KY; Ng CJR; Wang Y; Yeo C; Tan VH
    J Am Heart Assoc; 2022 Jun; 11(11):e024756. PubMed ID: 35656975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
    Nazer B; Dale Z; Carrassa G; Reza N; Ustunkaya T; Papoutsidakis N; Gray A; Howell SJ; Elman MR; Pieragnoli P; Ricciardi G; Jacoby D; Frankel DS; Owens A; Olivotto I; Heitner SB
    Heart Rhythm; 2020 Jul; 17(7):1107-1114. PubMed ID: 32084597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
    Gold MR; Lambiase PD; El-Chami MF; Knops RE; Aasbo JD; Bongiorni MG; Russo AM; Deharo JC; Burke MC; Dinerman J; Barr CS; Shaik N; Carter N; Stoltz T; Stein KM; Brisben AJ; Boersma LVA;
    Circulation; 2021 Jan; 143(1):7-17. PubMed ID: 33073614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy.
    Schukro C; Santer D; Prenner G; Stühlinger M; Martinek M; Teubl A; Moertl D; Schwarz S; Nürnberg M; Fiedler L; Hatala R; Khazen C
    Clin Cardiol; 2020 Oct; 43(10):1084-1092. PubMed ID: 32794309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epicardial vs. transvenous implantable cardioverter defibrillators in children.
    Le Bos PA; Pontailler M; Maltret A; Kraiche D; Gaudin R; Barbanti C; Marijon E; Raisky O; Bonnet D; Waldmann V
    Europace; 2023 Mar; 25(3):961-968. PubMed ID: 36735263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis.
    Rordorf R; Casula M; Pezza L; Fortuni F; Sanzo A; Savastano S; Vicentini A
    Heart Rhythm; 2021 Mar; 18(3):382-391. PubMed ID: 33212250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience.
    Wieniawski P; Buczyński M; Grabowski M; Winter J; Werner B
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR
    Gleva MJ; Wang Y; Curtis JP; Berul CI; Huddleston CB; Poole JE
    Am J Cardiol; 2017 Nov; 120(10):1891-1898. PubMed ID: 28917495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
    Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
    Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implantable cardioverter-defibrillators in children.
    Blom NA
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S32-4. PubMed ID: 18226032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subcutaneous implantable cardioverter-defibrillator: Initial experience.
    Galvão P; Cavaco D; Adragão P; Costa F; Carmo P; Morgado F; Bernardo R; Nunes M; Abecasis M; Neves J; Mendes M
    Rev Port Cardiol; 2014 Sep; 33(9):511-7. PubMed ID: 25242675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epicardial Devices in Pediatrics and Congenital Heart Disease.
    Tan RB; Stephenson EA; Bulic A
    Card Electrophysiol Clin; 2023 Dec; 15(4):467-480. PubMed ID: 37865520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
    Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of SubcutAneous implantable cardioVErter-defibrillators in ≤18 year-old CHILDREN: SAVE-CHILDREN registry.
    Mori H; Sumitomo N; Tsutsui K; Fukunaga H; Hayashi H; Nakajima H; Muraji S; Nabeshima T; Kawano D; Ikeda Y; Asano S; Nitta J; Watanabe S; Hokosaki T; Sato S; Chisaka T; Higaki T; Nakajima T; Tamura S; Kaneko Y; Ikeda K; Okada A; Kobayashi H; Motoki H; Minamiguchi H; Imamura T; Shizuta S; Kawamura M; Munetsugu Y; Suzuki T; Murakami T; Horigome H; Wada T; Takamuro M; Ozawa J; Suzuki H; Izumi D; Otsuki S; Chinushi M; Kato K; Miura M; Maeda J; Fukunaga M; Kondo H; Takahashi N; Tobiume T; Morishima I; Kuraishi K; Nakamura K; Hayashi H; Suzuki H; Yoshida Y; Fukamizu S; Hojo R; Nuruki N; Yoshinaga M; Hayashi K; Fukaya H; Kishihara J; Kobayashi T; Kato R
    Int J Cardiol; 2023 Jan; 371():204-210. PubMed ID: 36087632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac resynchronization and implantable defibrillators in adults with congenital heart disease.
    Chubb H; Motonaga KS
    Heart Fail Rev; 2020 Jul; 25(4):657-670. PubMed ID: 31754907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical experience with subcutaneous implantable cardioverter-defibrillators.
    Lewis GF; Gold MR
    Nat Rev Cardiol; 2015 Jul; 12(7):398-405. PubMed ID: 25898263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator.
    Coutinho Cruz M; Viveiros Monteiro A; Portugal G; Laranjo S; Lousinha A; Valente B; Osório P; Silva Cunha P; de Sousa L; Oliveira JA; Agapito A; Martins Oliveira M; Pinto F; Cruz Ferreira R
    Congenit Heart Dis; 2019 Jul; 14(4):525-533. PubMed ID: 30889316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.